Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene and cell therapies, and consumer health products, today announced that it will release financial results for the third quarter of fiscal year 2020 ended March 31, 2020, before the market open on Tuesday, May 5, 2020.
April 15, 2020
· 1 min read
